Skip to main navigation Skip to search Skip to main content

A randomized controlled trial of eplerenone in asymptomatic phospholamban p.Arg14del carriers

  • Remco de Brouwer
  • , Wouter P. te Rijdt
  • , Edgar T. Hoorntje
  • , Ahmad Amin
  • , Folkert W. Asselbergs
  • , Moniek G.P.J. Cox
  • , Jeroen F. van der Heijden
  • , Hans Hillege
  • , Jacco C. Karper
  • , Belend Mahmoud
  • , Peter van der Meer
  • , Anton Oomen
  • , Anneline S.J.M. te Riele
  • , Herman H.W. Silljé
  • , Hanno L. Tan
  • , Jan Peter van Tintelen
  • , Dirk J. van Veldhuisen
  • , Berend Daan Westenbrink
  • , Ans C.P. Wiesfeld
  • , Tineke P. Willems
  • Paul A. van der Zwaag, Arthur A.M. Wilde, Rudolf A. de Boer*, Maarten P. van den Berg
*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

5 Downloads (Pure)
Original languageEnglish
Pages (from-to)4284-4287
Number of pages4
JournalEuropean heart journal
Volume44
Issue number40
DOIs
Publication statusPublished - 21 Oct 2023

Keywords

  • Cardiomyopathy
  • Eplerenone
  • Fibrosis
  • Heart failure
  • Phospholamban
  • Randomized clinical trial

Cite this